Use and misuse of common terminology criteria for adverse events in cancer clinical trials

Podobne zapisy

• Use of patient-reported outcomes version of the common terminology criteria for adverse events in oncology clinical trials
  od: Lauren Rogak, i wsp.
  Wydane: (2025-10-01)
• Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events
  od: Miller, Tamara P., i wsp.
  Wydane: (2019)
• ReCAP: Identifying Severe Adverse Event Clusters Using the National Cancer Institute’s Common Terminology Criteria for Adverse Events
  od: Zhong, Xiaobo, i wsp.
  Wydane: (2016)
• Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
  od: Chung, Arlene E, i wsp.
  Wydane: (2019)
• Validity and Reliability of the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events
  od: Reeve, Bryce B, i wsp.
  Wydane: (2020)